BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31930767)

  • 1. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
    Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
    Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs and Extracellular Vesicles as Distinctive Biomarkers of Precocious and Advanced Stages of Breast Cancer Brain Metastases Development.
    Figueira I; Godinho-Pereira J; Galego S; Maia J; Haskó J; Molnár K; Malhó R; Costa-Silva B; Wilhelm I; Krizbai IA; Brito MA
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative Bioinformatics Analysis Reveals That miR-524-5p/MEF2C Regulates Bone Metastasis in Prostate Cancer and Breast Cancer.
    Tian Q; Lu Y; Yan B; Wu C
    Comput Math Methods Med; 2022; 2022():5211329. PubMed ID: 36128051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocyte Enhancer Factor 2C as a New Player in Human Breast Cancer Brain Metastases.
    Galego S; Kauppila LA; Malhó R; Pimentel J; Brito MA
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEF2C and miR-194-5p: New Players in Triple Negative Breast Cancer Tumorigenesis.
    Caetano S; Garcia AR; Figueira I; Brito MA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
    An M; Zang X; Wang J; Kang J; Tan X; Fu B
    Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B.
    Xun J; Du L; Gao R; Shen L; Wang D; Kang L; Chen C; Zhang Z; Zhang Y; Yue S; Feng S; Xiang R; Mi X; Tan X
    Theranostics; 2021; 11(14):6847-6859. PubMed ID: 34093857
    [No Abstract]   [Full Text] [Related]  

  • 8. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.
    Zeng H; Wang J; Chen T; Zhang K; Chen J; Wang L; Li H; Tuluhong D; Li J; Wang S
    Cancer Sci; 2019 Jan; 110(1):289-302. PubMed ID: 30443959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases.
    Sirkisoon SR; Wong GL; Aguayo NR; Doheny DL; Zhu D; Regua AT; Arrigo A; Manore SG; Wagner C; Thomas A; Singh R; Xing F; Jin G; Watabe K; Lo HW
    Cancer Lett; 2022 Aug; 540():215726. PubMed ID: 35589002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.
    Xu Z; Han Y; Liu J; Jiang F; Hu H; Wang Y; Liu Q; Gong Y; Li X
    Sci Rep; 2015 Jul; 5():12276. PubMed ID: 26184978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEF2C-AS1 regulates its nearby gene MEF2C to mediate cervical cancer cell malignant phenotypes in vitro.
    Guo Q; Zhang L; Zhao L; Pang X; Wang P; Sun H; Liu S
    Biochem Biophys Res Commun; 2022 Dec; 632():48-54. PubMed ID: 36198203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
    Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
    Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
    World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival.
    Giannoudis A; Clarke K; Zakaria R; Varešlija D; Farahani M; Rainbow L; Platt-Higgins A; Ruthven S; Brougham KA; Rudland PS; Jenkinson MD; Young LS; Falciani F; Palmieri C
    Sci Rep; 2019 Dec; 9(1):18518. PubMed ID: 31811234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.